Suppr超能文献

G通路调节血小板中的近端C型凝集素样受体2(CLEC-2)信号传导。

G pathway regulates proximal C-type lectin-like receptor-2 (CLEC-2) signaling in platelets.

作者信息

Badolia Rachit, Inamdar Vaishali, Manne Bhanu Kanth, Dangelmaier Carol, Eble Johannes A, Kunapuli Satya P

机构信息

From the Department of Physiology.

Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania 19140 and.

出版信息

J Biol Chem. 2017 Sep 1;292(35):14516-14531. doi: 10.1074/jbc.M117.791012. Epub 2017 Jul 13.

Abstract

Platelets play a key role in the physiological hemostasis or pathological process of thrombosis. Rhodocytin, an agonist of the C-type lectin-like receptor-2 (CLEC-2), elicits powerful platelet activation signals in conjunction with Src family kinases (SFKs), spleen tyrosine kinase (Syk), and phospholipase γ2 (PLCγ2). Previous reports have shown that rhodocytin-induced platelet aggregation depends on secondary mediators such as thromboxane A2 (TxA2) and ADP, which are agonists for G-protein-coupled receptors (GPCRs) on platelets. How the secondary mediators regulate CLEC-2-mediated platelet activation in terms of signaling is not clearly defined. In this study, we report that CLEC-2-induced Syk and PLCγ2 phosphorylation is potentiated by TxA2 and that TxA2 plays a critical role in the most proximal event of CLEC-2 signaling, the CLEC-2 receptor tyrosine phosphorylation. We show that the activation of other GPCRs, such as the ADP receptors and protease-activated receptors, can also potentiate CLEC-2 signaling. By using the specific G inhibitor, UBO-QIC, or G knock-out murine platelets, we demonstrate that G signaling, but not other G-proteins, is essential for GPCR-induced potentiation of Syk phosphorylation downstream of CLEC-2. We further elucidated the signaling downstream of G and identified an important role for the PLCβ-PKCα pathway, possibly regulating activation of SFKs, which are crucial for initiation of CLEC-2 signaling. Together, these results provide evidence for novel G-PLCβ-PKCα-mediated regulation of proximal CLEC-2 signaling by G-coupled receptors.

摘要

血小板在生理性止血或血栓形成的病理过程中发挥关键作用。红树凝血素是C型凝集素样受体2(CLEC-2)的激动剂,与Src家族激酶(SFK)、脾酪氨酸激酶(Syk)和磷脂酶γ2(PLCγ2)共同引发强大的血小板激活信号。先前的报道表明,红树凝血素诱导的血小板聚集依赖于血栓素A2(TxA2)和ADP等二级介质,它们是血小板上G蛋白偶联受体(GPCR)的激动剂。二级介质如何在信号传导方面调节CLEC-2介导的血小板激活尚不清楚。在本研究中,我们报告TxA2增强了CLEC-2诱导的Syk和PLCγ2磷酸化,并且TxA2在CLEC-2信号传导的最近端事件即CLEC-2受体酪氨酸磷酸化中起关键作用。我们表明,其他GPCR如ADP受体和蛋白酶激活受体的激活也能增强CLEC-2信号传导。通过使用特异性G抑制剂UBO-QIC或G基因敲除小鼠血小板,我们证明G信号传导而非其他G蛋白对于GPCR诱导的CLEC-2下游Syk磷酸化增强至关重要。我们进一步阐明了G下游的信号传导,并确定了PLCβ-PKCα途径的重要作用,其可能调节SFK的激活,而SFK对于CLEC-2信号传导的启动至关重要。总之,这些结果为G偶联受体对近端CLEC-2信号传导的新型G-PLCβ-PKCα介导的调节提供了证据。

相似文献

1
G pathway regulates proximal C-type lectin-like receptor-2 (CLEC-2) signaling in platelets.
J Biol Chem. 2017 Sep 1;292(35):14516-14531. doi: 10.1074/jbc.M117.791012. Epub 2017 Jul 13.
3
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2.
Blood. 2006 Jan 15;107(2):542-9. doi: 10.1182/blood-2005-05-1994. Epub 2005 Sep 20.
4
A Comprehensive Tyrosine Phosphoproteomic Analysis Reveals Novel Components of the Platelet CLEC-2 Signaling Cascade.
Thromb Haemost. 2020 Feb;120(2):262-276. doi: 10.1055/s-0039-3400295. Epub 2020 Jan 4.
5
Syk-dependent phosphorylation of CLEC-2: a novel mechanism of hem-immunoreceptor tyrosine-based activation motif signaling.
J Biol Chem. 2011 Feb 11;286(6):4107-16. doi: 10.1074/jbc.M110.167502. Epub 2010 Nov 22.
6
Characterization of UBO-QIC as a Gαq inhibitor in platelets.
Platelets. 2015;26(8):771-8. doi: 10.3109/09537104.2014.998993. Epub 2015 Mar 3.
7
C-type lectin-like receptor-2 (CLEC-2) is a key regulator of kappa-carrageenan-induced tail thrombosis model in mice.
Platelets. 2023 Dec;34(1):2281941. doi: 10.1080/09537104.2023.2281941. Epub 2023 Nov 27.
8
9
Botrocetin/VWF-induced signaling through GPIb-IX-V produces TxA2 in an alphaIIbbeta3- and aggregation-independent manner.
Blood. 2005 Oct 15;106(8):2750-6. doi: 10.1182/blood-2005-04-1667. Epub 2005 Jun 28.
10
The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.
J Thromb Haemost. 2009 Jul;7(7):1192-9. doi: 10.1111/j.1538-7836.2009.03451.x. Epub 2009 Apr 24.

引用本文的文献

1
C-type lectin-like receptor 2: roles and drug target.
Thromb J. 2024 Mar 19;22(1):27. doi: 10.1186/s12959-024-00594-8.
2
Platelet and HIV Interactions and Their Contribution to Non-AIDS Comorbidities.
Biomolecules. 2023 Nov 2;13(11):1608. doi: 10.3390/biom13111608.
3
SARS-CoV-2 vaccination induced cerebral venous sinus thrombosis: Do megakaryocytes, platelets and lipid mediators make up the orchestra?
Free Neuropathol. 2021 Jul 7;2:18. doi: 10.17879/freeneuropathology-2021-3395. eCollection 2021 Jan.
4
Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin.
Biomedicines. 2023 Jan 25;11(2):338. doi: 10.3390/biomedicines11020338.
5
Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches.
Int J Mol Sci. 2022 Mar 18;23(6):3301. doi: 10.3390/ijms23063301.
6
A Comparative Assessment Study of Known Small-molecule GPVI Modulators.
ACS Med Chem Lett. 2022 Jan 20;13(2):171-181. doi: 10.1021/acsmedchemlett.1c00414. eCollection 2022 Feb 10.
7
Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath.
Expert Opin Ther Targets. 2022 Jan;26(1):13-28. doi: 10.1080/14728222.2022.2031975. Epub 2022 Feb 22.
8
Platelets in HIV: A Guardian of Host Defence or Transient Reservoir of the Virus?
Front Immunol. 2021 Apr 23;12:649465. doi: 10.3389/fimmu.2021.649465. eCollection 2021.
9
Macrocyclic Gq Protein Inhibitors FR900359 and/or YM-254890-Fit for Translation?
ACS Pharmacol Transl Sci. 2021 Feb 19;4(2):888-897. doi: 10.1021/acsptsci.1c00021. eCollection 2021 Apr 9.
10
Diverse innate stimuli activate basophils through pathways involving Syk and IκB kinases.
Proc Natl Acad Sci U S A. 2021 Mar 23;118(12). doi: 10.1073/pnas.2019524118.

本文引用的文献

3
Critical off-target effects of the widely used Rac1 inhibitors NSC23766 and EHT1864 in mouse platelets.
J Thromb Haemost. 2015 May;13(5):827-38. doi: 10.1111/jth.12861. Epub 2015 Feb 23.
4
Dual-specificity phosphatase 3 deficiency or inhibition limits platelet activation and arterial thrombosis.
Circulation. 2015 Feb 17;131(7):656-68. doi: 10.1161/CIRCULATIONAHA.114.010186. Epub 2014 Dec 17.
6
Src family kinases: at the forefront of platelet activation.
Blood. 2014 Sep 25;124(13):2013-24. doi: 10.1182/blood-2014-01-453134. Epub 2014 Aug 12.
7
Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity.
Circ Res. 2014 Mar 28;114(7):1174-84. doi: 10.1161/CIRCRESAHA.114.301611.
9
Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2.
Nature. 2013 Oct 3;502(7469):105-9. doi: 10.1038/nature12501. Epub 2013 Sep 1.
10
Distinct role of Pyk2 in mediating thromboxane generation downstream of both G12/13 and integrin αIIbβ3 in platelets.
J Biol Chem. 2013 Jun 21;288(25):18194-203. doi: 10.1074/jbc.M113.461087. Epub 2013 May 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验